Federal Competition and Consumer Protection Commission (FCCPC) has met with stakeholders in the pharmaceutical industry over the high cost of medications in Nigeria.
Gatekeepers News reports that Tunji Bello, executive vice-chairman and chief executive officer of FCCPC revealed this at the launch of an inquiry in Abuja on Wednesday.
Bello noted that the engagement was necessary as it has become difficult for Nigerians to get access to affordable medications.
FCCPC CEO represented by Boladale Adeyinka, the commission’s director of surveillance and investigations, expressed belief that the engagement would provide solutions to the troubling issue.
He said, “As part of our mandate, we are conducting an inquiry into the high cost and variation of drug prices in Nigeria.”
“It has become obvious that the cost of medications has risen significantly over the past year, making it increasingly difficult for Nigerian consumers to afford the treatment they need.”
“The high cost of drugs not only affects patients’ health outcomes but also places a strain on our health care system.”
“The Commission has received consumer complaints regarding the variation and high costs of drugs in Nigerian Markets.”
“This inquiry is aimed to identify factors contributing to disparities in healthcare accessibility and affordability, particularly regarding drug pricing.”
“We believe this is crucial to ensuring Nigerians have access to quality and affordable healthcare services.”
On her part, Salamatu Orakwelu, chairman of Pharmaceutical Society of Nigeria (PSN), FCT branch, said access to affordable and quality medicine is a fundamental pillar of healthcare.
She said, “As pharmacists, we remain committed to ensuring equity, transparency, and sustainability in the pharmaceutical supply chain.”
“Collaborative efforts between policymakers, healthcare professionals, and industry players are crucial in tackling these challenges and safeguarding patients’ wellbeing.”
“The PSN stands ready to support initiatives that promote price stability, enhance drug accessibility, and strengthen the NHIA for the benefit of all Nigerians. Together, we can build a healthcare system that truly serves the people.”
Orakwelu called for the government’s intervention by “taking a bold step of regulating the prices of medications” that will go a long way.
